Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-16 Sale | 2021-04-19 8:04 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 171,853 | $38 | $6,530,414 | 0 (Indirect Direct) | View |
| 2021-04-16 Sale | 2021-04-19 7:57 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 138,947 | $38 | $5,279,986 | 0 (Direct) | View |
| 2021-04-16 Sale | 2021-04-19 7:53 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 135,547 | $38 | $5,150,786 | 0 (Direct) | View |
| 2021-04-16 Sale | 2021-04-19 7:49 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 33,423 | $38 | $1,270,074 | 0 (Direct) | View |
| 2021-04-16 Sale | 2021-04-19 7:42 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 5,000 | $38 | $190,000 | 0 (Direct) | View |
| 2021-04-16 Sale | 2021-04-19 7:21 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 68,971 | $38 | $2,620,898 | 0 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 5:29 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanaton of Responses | 7,393,340 | $20.19 | $149,247,137 | 81,263 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 12:17 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 78,959 | $22.5 | $1,776,578 | 62,408 (Direct) | View |
| 2020-11-04 Purchase | 2020-11-06 6:30 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 446,562 | $4.8909 | $2,184,092 | 583,912 (Direct) | View |
| 2020-10-06 Purchase | 2020-10-08 5:27 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 345,241 | $5.035 | $1,738,288 | 566,223 (Direct) | View |
| 2020-09-22 Purchase | 2020-09-24 7:49 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 32 | $3.7987 | $122 | 7,839,008 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-16 Option Award | 2021-04-19 8:04 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 66,000 | $0 | 0 (Direct) | View |
| 2021-04-01 Gift | 2021-04-19 8:04 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 21,254 | $0 | 0 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-19 7:57 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 66,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 66,000 | $0 | 0 (Direct) | View |
| 2021-03-31 Gift | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 8,085 | $0 | 0 (Direct) | View |
| 2021-04-05 Gift | 2021-04-19 7:46 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 10,000 | $0 | 0 (Direct) | View |
| 2021-04-09 Tax Withholding | 2021-04-13 1:05 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 11,088 | $37.94 | 68,971 (Direct) | View |
Ownership | 2021-03-08 4:58 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 6,262,085 (Direct) | View |
| 2021-02-26 Tax Withholding | 2021-03-02 12:16 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 1,158 | $22.23 | 123,433 (Direct) | View |
| 2021-02-26 Tax Withholding | 2021-03-02 12:08 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,158 | $22.23 | 77,632 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 1,461 | $22.23 | 33,423 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 2:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 1,653 | $23.08 | 124,591 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 5,100 | $25.71 | 124,591 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 2:36 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,653 | $23.08 | 78,790 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:36 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 5,091 | $25.71 | 78,790 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:31 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 5,110 | $25.71 | 72,947 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:26 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 1,155 | $25.71 | 34,884 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:19 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 22,000 | $0 | 126,427 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:19 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 11,583 | $16.14 | 126,427 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:09 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 22,000 | $0 | 78,057 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:09 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 11,504 | $16.14 | 78,057 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 22,000 | $0 | 85,534 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 11,583 | $16.14 | 85,534 (Direct) | View |
| 2020-11-26 Tax Withholding | 2020-11-30 2:49 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 6,920 | $18.45 | 67,561 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:38 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 11,001 | $18 | 138,010 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:38 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 22,000 | $0 | 138,010 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:29 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 10,908 | $18 | 96,481 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:29 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 22,000 | $0 | 96,481 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 11,039 | $18 | 97,117 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 22,000 | $0 | 97,117 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:17 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 52,959 | $2.22 | 62,408 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:17 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 26,000 | $2.8 | 62,408 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:17 pm | N/A 2030-03-18 | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 78,959 | $0 | 62,408 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 1:51 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 6,916 | $4.7 | 36,039 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 1:46 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 827 | $4.69 | 64,156 (Direct) | View |